Levels of circulating IL-6 are elevated in cancer patients compared to adenoma patients or healthy subjects and correlate with larger tumor size, the occurrence of liver metastases, relapse, and reduced survival in CRC and colitis-associated cancers (CAC) [79,80]. This evidence concerns the gene IL6 and cancer.